Expression and Significance of Glucose Transporter 1 and Tumor Proliferating Karyon Antigen Ki-67 in Epithelial Ovarian Tumor_West China Medical Journal

Authors：

WANG Anqun ¹ , LIU Jingzhi ² ,  YANG Yonghong ¹ , XIE Gang ¹ , XIE Chunyan ¹ , YUAN Qinghui ¹ , CHEN Zhongshu ¹ , YU Jiang ¹ , WU Xiaoge ¹ , LIU Shengjun ¹

1. Department of Pathology, Central Hospital of Mianyang, Mianyang, Sichuan 621000, P.R. China. 2. Department of Pathology, Sichuan College of Traditional Chinese Medicine, Mianyang, Sichuan 621000, P.R. China;

Corresponding author：

YANG Yonghong, Email: xiex1975@hotmail.com

Keywords：

卵巢上皮性肿瘤; 葡萄糖转运蛋白Ⅰ型; 肿瘤增殖细胞核抗原; 预后

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

【摘要】　目的　探讨葡萄糖转运蛋白Ⅰ型（glucose transporter 1，GLUT1）和肿瘤增殖细胞核抗原Ki-67在卵巢上皮性肿瘤组织中的表达及其临床意义。　方法　收集2000年1月-2008年6月不同卵巢上皮性肿瘤病变患者119例的组织标本，采用免疫组织化学SP二步法检测肿瘤组织中GLUT1和Ki-67的表达情况。　结果　卵巢交界性、恶性上皮性肿瘤灶性或广泛高表达GLUT1和Ki-67，其表达强度有差异。卵巢良性上皮性肿瘤不表达GLUT1和Ki-67。在卵巢癌中GLUT1及Ki-67的表达强度与病理分级、临床分期、预后有关。GLUT1表达强度与病理分型无关，Ki-67表达强度与病理分型有关。　结论　卵巢上皮性肿瘤组织中GLUT1和Ki-67的表达具有相关性，其表达强度与肿瘤的良恶性质和增殖状态有关，二者同时检测可以全面了解卵巢上皮性肿瘤的性质、卵巢癌恶性程度和生物学行为，对于判断肿瘤的性质和预后有一定价值。
【Abstract】　Objective　 To investigate the expression and clinical significance of glucose transporter-1 (GLUT1) and tumor proliferating karyon antigen Ki-67 in epithelial ovarian tumor tissue.　Methods　 Immunohistochemistry SP method was used to detect the expression of GLUT1 and Ki-67 protein in epithelial ovarian tumor tissues from 119 patients diagnosed in our hospital from January 2000 to June 2008.　Results　 The expressions of GLUT1 and Ki-67 had local or abroad higher expressions in the borderline and malignant epithelial ovarian tumor, and the expressive intensity was different. In benign tumors, the expression was negative. The expressive intensity of GLUT1 and Ki-67 had correlation with the grade, stage, and prognosis in malignant tumors. The expressive intensity of GLUT1 had no correlation with the type of malignant tumors, while Ki-67 related to the pathological types.　Conclusion　 The expressions of GLUT1 and Ki-67 have relativity. The expressive intensity of GLUT1 and Ki-67 relates to the character and proliferation of epithelial ovarian tumors. The combined detection GLUT1 and Ki-67 is helpful to know the character of epithelial ovarian tumors, the malignant degree and biologic behavior of ovarian carcinoma, which is useful in estimating the character and prognosis of epithelial ovarian tumors.

Citation： WANG Anqun,LIU Jingzhi,YANG Yonghong,XIE Gang,XIE Chunyan,YUAN Qinghui,CHEN Zhongshu,YU Jiang,WU Xiaoge,LIU Shengjun. Expression and Significance of Glucose Transporter 1 and Tumor Proliferating Karyon Antigen Ki-67 in Epithelial Ovarian Tumor. West China Medical Journal, 2011, 26(1): 63-65. doi: Copy

1.	Rudlowski C, Moser M, Becker AJ, et al. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer[J]. Oncology, 2004, 66(5): 404-410.
2.	Khouja MH, Baekelandt M, Nesland JM, et al. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma[J]. Int J Gynecol Pathol, 2007, 26(4): 418-425.
3.	Wood IS, Trayhum P. Glucose transporters (GLUT1 and SGLT): expanded families of sugar transpost proteins[J]. Br J Nutr, 2003, 89(1): 3-9.
4.	Younes M, Lechago LV, Somoano JR, et al. Wide expression of the human erythrocyte glucose transporter GLUT1 in human cancers[J]. Cancer Res, 1996, 56(5): 1164-1167.
5.	蔡昱, 邵淑丽. GLUT1研究进展[J]. 国外医学•肿瘤学分册, 2004, 31(增刊): 50-51.
6.	Kalir T, Wang BY, Goldfischer M, et al. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia[J]. Cancer, 2002, 94(4): 1078-1082.
7.	Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis[J]. Cancer, 1998, 83(1): 34-40.
8.	Cantuaria G, Magalhaes A, Angioli R, et al. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma [J]. Cancer, 2000, 88(2): 381-388.
9.	颜琳, 吴绪峰, 陈惠祯. PTEN和Ki-67在上皮性卵巢癌中的表达及意义[J]. 现代肿瘤医学, 2005, 13(2): 151-153.
10.	任琼珍, 钱志红, 胡建铭. Ki-67在卵巢癌中的表达及意义[J]. 苏州大学学报, 2006, 26(2): 321.

1. 　Rudlowski C, Moser M, Becker AJ, et al. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer[J]. Oncology, 2004, 66(5): 404-410.
2. 　Khouja MH, Baekelandt M, Nesland JM, et al. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma[J]. Int J Gynecol Pathol, 2007, 26(4): 418-425.
3. 　Wood IS, Trayhum P. Glucose transporters (GLUT1 and SGLT): expanded families of sugar transpost proteins[J]. Br J Nutr, 2003, 89(1): 3-9.
4. 　Younes M, Lechago LV, Somoano JR, et al. Wide expression of the human erythrocyte glucose transporter GLUT1 in human cancers[J]. Cancer Res, 1996, 56(5): 1164-1167.
5. 　蔡昱, 邵淑丽. GLUT1研究进展[J]. 国外医学•肿瘤学分册, 2004, 31(增刊): 50-51.
6. 　Kalir T, Wang BY, Goldfischer M, et al. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia[J]. Cancer, 2002, 94(4): 1078-1082.
7. 　Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis[J]. Cancer, 1998, 83(1): 34-40.
8. 　Cantuaria G, Magalhaes A, Angioli R, et al. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma [J]. Cancer, 2000, 88(2): 381-388.
9. 　颜琳, 吴绪峰, 陈惠祯. PTEN和Ki-67在上皮性卵巢癌中的表达及意义[J]. 现代肿瘤医学, 2005, 13(2): 151-153.
10. 　任琼珍, 钱志红, 胡建铭. Ki-67在卵巢癌中的表达及意义[J]. 苏州大学学报, 2006, 26(2): 321.

West China Medical Journal

Expression and Significance of Glucose Transporter 1 and Tumor Proliferating Karyon Antigen Ki-67 in Epithelial Ovarian Tumor

Abstract Full text Figures/Tables Video References Cited by

Format

Content